Evidence map›Paper›PMID 35028863›Full record

ArticleMedical & biological engineering & computing2022

Hybrid gene selection approach using XGBoost and multi-objective genetic algorithm for cancer classification.

Xiongshi Deng, Min Li, Shaobo Deng, Lei Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Medical & biological engineering & computing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiongshi DengSchool of Information Engineering, Nanchang Institute of Technology, Jiangxi, 330099, People's Republic of China.
Min LiSchool of Information Engineering, Nanchang Institute of Technology, Jiangxi, 330099, People's Republic of China. liminghuadi@hotmail.com.
Shaobo DengSchool of Information Engineering, Nanchang Institute of Technology, Jiangxi, 330099, People's Republic of China.
Lei WangSchool of Information Engineering, Nanchang Institute of Technology, Jiangxi, 330099, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microarray gene expression data are often accompanied by a large number of genes and a small number of samples. However, only a few of these genes are relevant to cancer, resulting in significant gene selection challenges. Hence, we propose a two-stage gene selection approach by combining extreme gradient boosting (XGBoost) and a multi-objective optimization genetic algorithm (XGBoost-MOGA) for cancer classification in microarray datasets. In the first stage, the genes are ranked using an ensemble-based feature selection using XGBoost. This stage can effectively remove irrelevant genes and yield a group comprising the most relevant genes related to the class. In the second stage, XGBoost-MOGA searches for an optimal gene subset based on the most relevant genes' group using a multi-objective optimization genetic algorithm. We performed comprehensive experiments to compare XGBoost-MOGA with other state-of-the-art feature selection methods using two well-known learning classifiers on 14 publicly available microarray expression datasets. The experimental results show that XGBoost-MOGA yields significantly better results than previous state-of-the-art algorithms in terms of various evaluation criteria, such as accuracy, F-score, precision, and recall.

Indexed as

AlgorithmsNeoplasmsHumansMicroarray AnalysisClassificationFeature selectionMicroarray gene expressionMulti-objective genetic algorithmXGBoost

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.